Empowering FDA-regulated companies to achieve, measure, and maintain effective GMP competency with data-driven precision.
ComplyIQPro™ is an intelligent GMP training and effectiveness management platform designed specifically for pharmaceutical, biotechnology, and medical device companies.
We go beyond traditional training — ensuring every employee is not just trained, but competent, qualified, and always audit-ready to perform GMP-critical tasks.
Built by Nasudo Group LLC (California), ComplyIQPro™ combines automation, analytics, and compliance intelligence to help organizations meet and maintain 21 CFR Part 211.25(a) requirements effortlessly.
With real-time dashboards, SOP-based assessments, and automated audit-ready reports, ComplyIQPro transforms your training program into measurable GMP performance.
By generating targeted questions and answers directly from your procedures and policies, the platform reinforces understanding of critical steps — closing the gap between training and verified compliance.
Traditional GMP training often ends at completion tracking—ComplyIQPro™ goes far beyond.
We redefine compliance by focusing on measurable competence, not just participation.
Employees engage with role-based learning tied directly to SOPs and real-world tasks.
Advanced analytics reveal trends, risks, and training gaps before they cause findings.
Supervisors gain a clear view of who’s compliant, who’s competent, and who needs support.
AI-driven insights help you anticipate and prevent non-conformances before audits.
With ComplyIQPro™, compliance becomes a living, measurable system—driving quality, safety, and readiness across your organization.
Whether you’re a startup preparing for your first FDA inspection or a global manufacturer managing multiple sites, ComplyIQPro™ adapts to your scale. Our customers trust us to keep training continuous, competency measurable, and compliance effortless.
“ComplyIQPro™ transformed our compliance culture. Training is now measurable, traceable, and inspection-ready every day.”